Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jacob Hughes's Stock Ratings
Wells Fargo Analyst
Jacob Hughes is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/27/2025
Overall Average Return
-1.31%
Smart Score
Overall Average Return Percentile
33rd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/17/2023 | AMPH | Buy Now | Amphastar Pharma | $23.04 | 90.97% | Jacob Hughes41% | $40 → $44 | Maintains | Equal-Weight | Get Alert |
| 03/02/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jacob Hughes41% | $262 → $257 | Reiterates | → Overweight | Get Alert |
| 11/04/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jacob Hughes41% | $264 → $262 | Maintains | Overweight | Get Alert |
| 09/06/2022 | PRGO | Buy Now | Perrigo | $26.43 | 104.35% | Jacob Hughes41% | → $54 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/25/2022 | RVNC | Buy Now | Revance Therapeutics | — | — | Jacob Hughes41% | $17 → $24 | Maintains | Equal-Weight | Get Alert |
| 08/16/2022 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.73 | 1675.47% | Jacob Hughes41% | $12 → $13 | Maintains | Equal-Weight | Get Alert |
| 08/10/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jacob Hughes41% | $186 → $264 | Maintains | Overweight | Get Alert |
| 05/18/2022 | MDWD | Buy Now | MediWound | $19.33 | -58.61% | Jacob Hughes41% | $7 → $8 | Maintains | Overweight | Get Alert |
| 05/04/2022 | EBS | Buy Now | Emergent BioSolutions | $6.28 | 505.1% | Jacob Hughes41% | $46 → $38 | Maintains | Equal-Weight | Get Alert |
| 03/15/2022 | AMPH | Buy Now | Amphastar Pharma | $23.04 | 38.89% | Jacob Hughes41% | $23 → $32 | Maintains | Equal-Weight | Get Alert |
| 03/10/2022 | EBS | Buy Now | Emergent BioSolutions | $6.28 | 536.94% | Jacob Hughes41% | $37 → $40 | Maintains | Equal-Weight | Get Alert |
| 10/25/2021 | RVNC | Buy Now | Revance Therapeutics | — | — | Jacob Hughes41% | → $17 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/29/2021 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | -33.95% | Jacob Hughes41% | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 03/17/2021 | AMPH | Buy Now | Amphastar Pharma | $23.04 | -13.19% | Jacob Hughes41% | $21 → $20 | Maintains | Equal-Weight | Get Alert |
| 01/08/2021 | EBS | Buy Now | Emergent BioSolutions | $6.28 | — | Jacob Hughes41% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/08/2021 | AMPH | Buy Now | Amphastar Pharma | $23.04 | -8.85% | Jacob Hughes41% | → $21 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/28/2020 | BHC | Buy Now | Bausch Health Companies | $6.50 | 161.34% | Jacob Hughes41% | $18 → $17 | Maintains | Equal-Weight | Get Alert |
| 09/30/2020 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.73 | 1129.17% | Jacob Hughes41% | → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/30/2020 | IRWD | Buy Now | Ironwood Pharmaceuticals | $0.73 | 1948.62% | Jacob Hughes41% | $16 → $15 | Maintains | Overweight | Get Alert |
| 04/30/2020 | BHC | Buy Now | Bausch Health Companies | $6.50 | 176.71% | Jacob Hughes41% | $17 → $18 | Maintains | Equal-Weight | Get Alert |
| 03/23/2020 | BHC | Buy Now | Bausch Health Companies | $6.50 | 161.34% | Jacob Hughes41% | $32 → $17 | Maintains | Equal-Weight | Get Alert |
| 03/05/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | -27.95% | Jacob Hughes41% | $10 → $12 | Maintains | Equal-Weight | Get Alert |
| 01/22/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | -39.96% | Jacob Hughes41% | $8 → $10 | Maintains | Equal-Weight | Get Alert |
| 01/22/2020 | BHC | Buy Now | Bausch Health Companies | $6.50 | — | Jacob Hughes41% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/30/2019 | RVNC | Buy Now | Revance Therapeutics | — | — | Jacob Hughes41% | $12.5 → $20 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/30/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | -51.97% | Jacob Hughes41% | $17 → $8 | Maintains | Market Perform | Get Alert |
| 05/09/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | 2.07% | Jacob Hughes41% | $18 → $17 | Maintains | Market Perform | Get Alert |
| 04/03/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | 8.08% | Jacob Hughes41% | $20 → $18 | Maintains | Market Perform | Get Alert |
| 02/15/2019 | RVNC | Buy Now | Revance Therapeutics | — | — | Jacob Hughes41% | — | Initiates | → Market Perform | Get Alert |
| 06/18/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | — | Jacob Hughes41% | — | Upgrade | Underperform → Market Perform | Get Alert |
| 01/05/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | — | Jacob Hughes41% | — | Downgrade | Market Perform → Underperform | Get Alert |
| 02/19/2016 | AMPH | Buy Now | Amphastar Pharma | $23.04 | — | Jacob Hughes41% | — | Initiates | → Outperform | Get Alert |
| 02/19/2016 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | — | Jacob Hughes41% | — | Initiates | → Outperform | Get Alert |
| 06/11/2014 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | — | Jacob Hughes41% | — | Initiates | → Market Perform | Get Alert |
| 03/18/2013 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.66 | — | Jacob Hughes41% | — | Downgrade | Outperform → Market Perform | Get Alert |
